Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
A Prospective, Randomized, Parallel, Multi-center, Active Controlled, Single Blind (Assessor), Phase 3 Clinical Trial in Bowel Preparation for Colonoscopy
This is a prospective, randomized, single-blind, parallel, active-controlled, and multi-center Phase III clinical trial.
100 Clinical Results associated with Gunkang Pharmaceuticals, Inc
0 Patents (Medical) associated with Gunkang Pharmaceuticals, Inc
100 Deals associated with Gunkang Pharmaceuticals, Inc
100 Translational Medicine associated with Gunkang Pharmaceuticals, Inc